Heska Corp (HSKA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CEO:
Kevin S. Wilson
Employees:
810
3760 ROCKY MOUNTAIN AVENUE, LOVELAND, CO 80538
9704937272

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment.

Data derived from most recent annual or quarterly report
Market Cap 1.31 Billion Shares Outstanding10.914 Million Avg 30-day Volume 330.473 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.92
Price to Revenue3.9793 Debt to Equity0.2291 EBITDA-4.578 Million
Price to Book Value2.4284 Operating Margin-7.559 Enterprise Value984.18 Million
Current Ratio5.641 EPS Growth-0.512 Quick Ratio3.824
1 Yr BETA 1.0282 52-week High/Low 120.03 / 57.83 Profit Margin-7.8576
Operating Cash Flow Growth-4.3434 Free Cash Flow to Firm (FCFF) TTM -50.218 Million Free Cash Flow to Equity (FCFE) TTM-12.202 Million
Altman Z-Score3.7749
View SEC Filings from HSKA instead.

View recent insider trading info

Heska Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding HSKA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HSKA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-06-14 by DAVIS STEPHEN L
  • 4: filed on 2023-06-14 by HASENMAIER JOACHIM A.
  • 4: filed on 2023-06-14 by EYL STEVEN M.
  • 4: filed on 2023-06-14 by MAPLES SHARON J.
  • 4: filed on 2023-06-14 by SVEEN DAVID E.
  • 4: filed on 2023-06-14 by FURLONG MARK F
  • 4: filed on 2023-06-14 by HUMPHREY SCOTT
  • 4: filed on 2023-06-14 by WILSON KEVIN S.
  • 4: filed on 2023-06-14 by BAKER ELEANOR F.
  • 4: filed on 2023-06-14 by GRASSMAN CATHERINE

    • Events (8k)

  • 8-K: filed on 2023-06-13:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-13:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-07:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-06-01:
    Item 8.01: Other Events
  • 8-K: filed on 2023-05-26:
    Item 8.01: Other Events
  • 8-K: filed on 2023-05-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-04-03:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ANTIN ROBERT L

    • Director
    		 0 2023-06-13 1

    FURLONG MARK F

    • Director
    		 0 2023-06-13 1

    MAPLES SHARON J.

    • Director
    		 0 2023-06-13 1

    DAVIS STEPHEN L

    • Director
    		 0 2023-06-13 1

    WILSON KEVIN S. CEO AND PRESIDENT

    • Officer
    • Director
    		 0 2023-06-13 4

    SVEEN DAVID E.

    • Director
    		 0 2023-06-13 1

    HUMPHREY SCOTT

    • Director
    		 0 2023-06-13 1

    PROVIDENTI ANTHONY C. JR. EVP, CORPORATE DEVELOPMENT

    • Officer
    		 0 2023-06-13 3

    HASENMAIER JOACHIM A.

    • Director
    		 0 2023-06-13 1

    GRASSMAN CATHERINE EVP, CFO

    • Officer
    		 14,261 2023-06-01 2

    EYL STEVEN M. EVP, CCO & PRES.SCIL

    • Officer
    		 26,904 2023-03-25 1

    BAKER ELEANOR F. EVP, MANAGING DIR. & COO, SCIL

    • Officer
    		 8,164 2023-03-25 1

    SVEEN CHRISTOPHER D. CAO & GENERAL COUNSEL

    • Officer
    		 8,486 2023-03-25 1

    WISNEWSKI NANCY CHIEF OPERATING OFFICER

    • Officer
    		 81,083 2022-09-01 0

    AROESTY JASON D EVP, INTERNATIONAL DIAGNOSTICS

    • Officer
    		 0 2020-11-27 0

    TROWBRIDGE BONNIE J.

    • Director
    		 4,089 2020-11-09 0

    NAPOLITANO JASON A CHIEF STRATEGY OFFICER

    • Officer
    		 62,799 2019-12-30 0

    GORDON G IRWIN

    • Director
    		 25,074 2018-11-29 0

    LIPPINCOTT ROD EVP, COMP. ANIMAL HEALTH SALES

    • Officer
    		 8,573 2018-08-31 0

    ASAKOWICZ STEVE EVP, COMP. ANIMAL HEALTH SALES

    • Officer
    		 8,400 2018-08-27 0

    WRENN CAROL

    • Director
    		 5,249 2018-05-03 0

    MCGINLEY MICHAEL J PRESI, BIOLOGIC. & PHARM.

    • Officer
    		 86,776 2018-03-17 0

    MCMAHON JOHN VP, CHIEF FINANCIAL OFFICER

    • Officer
    		 68 2017-08-30 0

    GRIEVE ROBERT B EXECUTIVE CHAIR

    • Officer
    • Director
    		 106,331 2015-08-28 0

    AYLESWORTH WILLIAM A

    • Director
    		 37,397 2015-03-09 0

    BENT MICHAEL A V.P.ACTG. OFFICER & CONTROLLER

    • Officer
    		 9,773 2012-12-28 0

    APERFINE JOSEPH EVP, SALES AND MARKETING

    • Officer
    		 0 2012-12-19 0

    ZACHARA CLAUDINE

    • VP, MARKETING
    		 0 2012-12-19 0

    CMC MASTER FUND, L.P.

    CMC MASTER FUND PARTNERS, LLC

    • 10% Owner
    		 No longer subject to file 2012-10-09 0

    SASEN JOHN F

    • Director
    		 0 2012-05-08 0

    EIO PETER

    • Director
    		 0 2012-05-08 0

    MCCORMICK LOUISE L.

    • Director
    		 0 2012-05-08 0

    CMC MASTER FUND, L.P.

    CMC MASTER FUND PARTNERS, LLC

    C.M. CAPITAL ADVISORS, LLC

    C.M. CAPITAL CORP

    • 10% Owner
    		 579,045 2012-02-15 0

    SNODGRASS GERALD L VP, SALES

    • Officer
    		 0 2009-11-10 0

    PACIFIC COAST INVESTORS LTD

    • 10% Owner
    		 No longer subject to file 2009-08-25 0

    FLANDERS JOHN R V.P., GENERAL COUNSEL

    • Officer
    		 32,500 2008-11-25 0

    CHARTER VENTURES II, L.P.

    CHARTER VENTURES

    • 10% Owner
    		 No longer subject to file 2008-06-20 0

    RITTER JOSEPH H EVP, GLOBAL BUS. OPERATIONS

    • Officer
    		 0 2007-12-31 0

    DOLAN A BARR

    • Director
    		 40,167 2007-05-04 0

    GILSON TODD M VP, MARKETING

    • Officer
    		 0 2007-03-09 0

    DEMARSE ELISABETH H

    • Director
    		 1,328 2006-11-20 0

    STEVENSON LYNNOR B

    • Director
    		 330,124 2006-03-29 0

    CHARTER LIFE SCIENCES I-IV LLC

    • 10% Owner
    		 0 2006-01-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    HESKA CORP HSKA 2023-06-13 22:15:03 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 21:45:06 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 21:15:05 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 20:45:03 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 20:15:05 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 19:45:03 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 19:15:04 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 18:45:04 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 18:15:03 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 17:45:03 UTC 4.4413 0.6187 300000
    HESKA CORP HSKA 2023-06-13 17:15:04 UTC 4.4413 0.6187 300000
    HESKA CORP HSKA 2023-06-13 16:45:04 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 16:15:04 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 15:45:04 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 15:15:04 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 14:45:03 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 14:15:03 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 13:45:04 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 13:15:04 UTC 4.6519 0.4081 300000
    HESKA CORP HSKA 2023-06-13 12:45:04 UTC 4.6519 0.4081 300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments